Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02630823
Title MK-3475 Immunotherapy in Endometrial Carcinoma
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Washington University School of Medicine

endometrial cancer


Carboplatin + Paclitaxel + Pembrolizumab

Age Groups: adult
Covered Countries USA

No variant requirements are available.